Related Experiment Video
Updated: May 7, 2025

Tissue Engineering of the Intestine in a Murine Model
Published on: December 1, 2012
Risk Factors and Treatment Strategies for Anastomotic Ulcers in Pediatric Intestinal Failure
Priyanka V Chugh1, Emily K Nes1, Hajar Fénnich1
1Department of Surgery, Boston Children's Hospital, Boston, MA, USA.
Insights
Anastomotic ulcers (AUs) affect 5.3% of pediatric intestinal failure (IF) patients. Increased bowel length and longer parenteral nutrition (PN) duration are risk factors, with most AUs managed medically.
Area of Science:
- Gastroenterology
- Pediatric Surgery
- Clinical Nutrition
Background:
- Anastomotic ulcers (AUs) are a rare complication in pediatric patients with intestinal failure (IF).
- Previous research on AUs consists of small, descriptive studies.
- Identifying risk factors and treatment strategies for AUs is crucial for managing IF patients.
Purpose of the Study:
- To evaluate a large cohort of IF patients to identify risk factors for anastomotic ulcers (AUs).
- To describe treatment strategies for AUs in children with intestinal failure (IF).
Main Methods:
- A retrospective, case-control study was conducted involving IF patients in a pediatric intestinal rehabilitation program (2013-2023).
- Cases were children with IF and peri-anastomotic ulceration confirmed by GI endoscopy, matched with two controls (IF patients without AU) based on sex and time since IF diagnosis.
- Conditional logistic regression was used to compare risk factors between cases and controls.
Main Results:
- Out of 588 screened patients, 31 (5.3%) were identified as cases with AUs.
- Multivariable analysis indicated that AU was associated with increased bowel length (OR 1.65 per 10% increase) and longer duration of parenteral nutrition (PN) (OR 1.68).
- Most patients (93.5%) were initially managed medically; however, 32.3% required red blood cell transfusions, and 8 patients ultimately required surgery or endoscopic coagulation.
Conclusions:
- Anastomotic ulcers (AUs) were identified in 5.3% of the studied intestinal failure (IF) patients.
- Increased percent expected bowel length and longer duration of parenteral nutrition (PN) were associated with a higher odds of developing AUs.
- While most AUs can be managed medically, surgical intervention may be necessary for select cases.
Purpose:
Anastomotic ulcers (AUs) are a rare cause of morbidity in intestinal failure (IF). Prior studies of AUs have been small, descriptive reports. We evaluated a large cohort of IF patients to identify risk factors and describe treatment strategies for AUs.
Methods:
This was a retrospective, case-control study of IF patients within an interdisciplinary pediatric intestinal rehabilitation program from 2013 to 2023. Each case was a child who had a bowel resection, with intestinal failure (IF) meeting the American Society for Parenteral and Enteral Nutrition (ASPEN) definition of IF, with localized, peri-anastomotic ulceration on GI endoscopy. Each case was matched with 2 controls (children with IF but without an AU diagnosis), based on sex and time since intestinal failure diagnosis. Cases and controls were compared using conditional logistic regression on clinically relevant risk factors.
Results:
Of 588 patients followed in our program and screened, 31 (5.3 %) cases were identified. Median duration from initial surgery to AU diagnosis was 6 years, and ulcers were noted to be close to the entero-colonic anastomosis in 23 (77.4 %). The ulcers were noted to be <50 % of circumference in 9 (29 %), ≥50 % circumference in 7 (22.6 %) and multiple in 15 (48.4 %). Median follow up after AU diagnosis was 2.17 years. On multivariable analysis, AU was associated with increased bowel length (OR 1.65 for each 10 % increase in percent expected bowel length, CI 1.01, 2.7) and longer duration of parenteral nutrition (PN) in years (OR 1.68, CI 1.09, 2.6). Of the 31 cases, 10 (32.3 %) required at least one red blood cell transfusion. Initial medical management with antibiotics, anti-inflammatory medications, and/or enteral steroids was utilized in 29 (93.5 %). Of these, 8 ultimately failed medical management, as defined by the clinical team, and underwent surgery (7) or endoscopic coagulation (1). Initial procedural intervention was performed with endoscopic coagulation in 1 case and surgery in 1 case, of which the patient required repeat surgery.
Conclusions:
In this large cohort of IF patients, AU occurred in 5.3 % of patients. Most patients can be managed medically but surgery may be ultimately required in select patients. The odds of AU increased with greater percent expected bowel length and longer PN duration.
Related Concept Videos
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Esophageal Perforation-II: Clinical Manifestations and Management
Clinical Manifestations:
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...

